更正:干扰素受体缺陷小鼠易患焦痂相关立克次体病
Correction: Interferon receptor-deficient mice are susceptible to eschar-associated rickettsiosis
生物技术与制药领域的最新动态
Correction: Interferon receptor-deficient mice are susceptible to eschar-associated rickettsiosis
Thermo Fisher Scientific (TMO) Stock Today: Alzheimer’s Registry Launch, Analyst Price Targets, and 2026 Catalysts (Dec. 18, 2025) - ts2.tech
Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
Is Waters Corporation stock attractive for retirement portfolios - 2025 Historical Comparison & Fast Entry and Exit Trade Plans - Улправда
Moon Surgical enters new phase, updating robots with AI connectivity
Karuna head, Teva alums meet minds to launch schizophrenia-focused biotech Syremis with $165M series A
GlucoModicum touts needle-free Sofio glucose monitoring patch
Verge Genomics drops sole clinical candidate in return to AI drug discovery roots
Moderna gets funding for H5 pandemic influenza vaccine
Science’s 2025 Breakthrough of the Year: The unstoppable rise of renewable energy
Endpoints biopharma sentiment survey for Q1 2026
AI startup Edison raises $70M seed for research software
Appointments and advancements for Dec. 18, 2025
Financings for Dec. 18, 2025
In the clinic for Dec. 18, 2025
Other news to note for Dec. 18, 2025
Regulatory actions for Dec. 18, 2025
Lilly obesity pill, headed for quick FDA review, hits mark in ‘maintenance’ trial
After year of triumph, Insmed stumbles with chronic rhinosinusitis fail, brings in new asset
Biopharma's winners and losers of 2025